Clinical Trial Update: IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency [Phase 3]

View source ↗

Summary

This is a Phase 3 trial update evaluating intravenous immunoglobulin (IVIG) for asthma in patients with IgG subclass deficiency. The current status of the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Asthma | Phase 3 | Status: UNKNOWN